Worries you, excites you, makes you think

US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - World-news https://ift.tt/3hX2lsF
Share:

Related Posts:

0 Comments:

Post a Comment

My Blog List

Support